Tenaya Therapeutics, Inc.
TNYA
$0.73
$0.00-0.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.51% | 21.52% | 18.48% | 19.59% | 17.49% |
| Total Depreciation and Amortization | -19.96% | -16.00% | -0.38% | 1.61% | 3.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 91.41% | -24.94% | -18.61% | -22.36% | -14.80% |
| Change in Net Operating Assets | 271.51% | 53.36% | 69.03% | 42.04% | 36.02% |
| Cash from Operations | 32.00% | 24.21% | 24.57% | 22.68% | 21.35% |
| Capital Expenditure | 71.19% | 70.85% | 39.71% | 37.86% | 12.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.41% | 18.25% | 2,529.92% | 366.19% | -4.52% |
| Cash from Investing | -72.45% | 20.94% | 4,858.71% | 351.88% | -4.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.49% | 14.41% | 128.03% | 6.86% | 6.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.78% | 12.67% | 127.03% | 5.86% | 5.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 239.74% | 567.98% | 331.19% | 164.81% | 126.03% |